Cantel medical corp. (CMD)
CashFlow / TTM
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10
Cash flows from operating activities
Net (loss) income

20,504

41,567

55,042

63,105

73,666

87,354

91,041

91,150

89,925

75,507

71,378

70,672

67,180

64,499

59,953

56,935

55,272

50,968

47,953

45,385

43,278

43,319

43,265

42,773

41,522

40,848

39,239

38,675

37,851

34,693

31,337

26,370

23,244

21,670

20,425

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation

26,162

23,157

21,510

20,112

18,846

18,128

17,473

16,939

16,087

15,627

15,045

14,157

13,444

12,621

11,989

11,873

11,532

11,202

10,692

9,746

9,131

8,620

8,245

7,894

7,595

7,379

7,202

7,052

6,981

6,884

6,801

6,849

6,859

6,808

6,759

0

0

0

Amortization

25,300

20,837

20,849

19,973

19,497

19,350

17,357

19,369

18,853

18,546

18,407

15,288

14,670

13,910

13,095

13,354

13,468

13,403

13,265

12,407

11,584

10,971

10,641

10,505

10,466

10,420

10,061

9,716

9,397

9,102

9,124

8,343

7,529

6,657

5,687

0

0

0

Stock-based compensation expense

15,215

15,390

15,562

14,467

11,188

10,340

9,615

8,894

8,396

7,773

8,844

9,507

9,804

9,563

8,361

7,350

6,461

6,006

5,867

5,785

5,854

5,842

5,409

4,905

4,402

3,923

3,733

3,627

3,414

3,867

3,840

3,816

3,981

3,516

3,350

0

0

0

Amortization of right-of-use assets

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

-1,433

66

-2,062

-2,692

-4,163

-8,974

-7,520

-7,284

-7,156

-1,019

118

-1,710

-1,577

-1,115

-1,710

-1,422

-1,437

-1,615

-1,449

-1,344

-1,117

-721

-1,218

-267

68

108

-368

1,458

1,380

1,236

370

-1,791

-1,789

-1,612

-1,799

0

0

0

Inventory step-up amortization

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

401

402

401

401

401

478

458

440

423

331

338

345

353

359

367

373

363

352

337

321

0

0

0

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-328

-434

-447

-360

-408

-242

-389

-501

-362

-340

-268

-184

-135

-209

-143

-105

-112

-55

-24

-10

0

0

0

Fair value adjustments to contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-620

-3,430

-3,324

-2,585

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-983

-643

1,179

2,092

2,246

2,184

3,168

3,238

3,557

4,268

4,391

4,704

4,304

4,558

2,875

2,641

3,176

2,665

1,970

1,600

1,206

974

776

0

0

0

Other non-cash items, net

1,740

3,724

1,940

-753

-623

-2,379

-1,076

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities, net of effects of acquisitions/dispositions:
Accounts receivable

10,433

19,309

23,048

23,234

11,754

16,371

3,700

-1,140

9,064

5,853

12,860

15,522

12,359

10,916

12,729

6,981

7,245

1,191

3,905

5,713

-1,360

4,178

6,149

7,986

7,372

6,580

2,447

3,841

4,343

5,095

-2,307

-2,206

460

4,658

13,449

0

0

0

Inventories

21,392

31,606

28,711

18,665

5,229

4,515

3,785

6,570

6,178

-82

-887

4,211

12,315

15,087

15,558

16,449

11,211

10,981

10,075

7,885

3,961

2,838

2,658

3,029

7,070

5,638

5,262

3,582

-59

1,154

2,227

3,940

4,166

5,312

2,038

0

0

0

Prepaid expenses and other assets

-930

2,306

2,364

2,842

6,010

-2,193

5,169

5,289

-532

4,429

957

737

1,444

117

2,850

5,589

4,208

7,747

2,996

3,479

4,985

1,808

2,388

1,291

766

677

1,387

910

765

-22

345

403

884

1,976

418

0

0

0

Accounts payable and other liabilities

748

-1,394

13,325

10,363

-48

18,348

10,614

11,763

10,224

5,735

7,124

12,359

16,795

15,372

17,657

16,634

4,709

-2,265

-3,347

-26

-1,725

4,705

6,205

5,547

7,890

4,673

931

-334

-4,393

1,769

-177

-26

-427

4,646

7,266

0

0

0

Income taxes

-418

-4,241

-1,232

3,055

3,819

-123

-1,090

-6,469

-4,536

686

-895

780

1,291

29

2,972

3,777

2,509

4,869

4,564

3,552

4,486

5,367

6,151

4,814

3,382

4,863

4,630

0

0

0

-

-

-

3,548

2,860

0

0

0

Operating lease liabilities

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

81,270

43,593

66,931

84,395

100,435

128,109

125,912

124,812

117,863

113,357

108,193

101,849

96,998

90,061

80,268

77,499

68,503

61,482

59,070

56,919

61,561

66,224

64,272

57,730

53,992

52,875

51,494

52,218

49,793

52,254

50,580

43,523

36,662

32,674

28,198

0

0

0

Capital expenditures

54,474

66,994

95,438

89,313

86,284

70,040

37,698

30,072

26,125

25,414

27,065

27,396

25,670

23,865

18,889

16,689

15,123

12,872

12,760

13,984

14,450

14,414

13,541

10,597

8,560

7,757

6,745

5,676

5,501

5,382

5,502

5,000

5,097

5,933

5,835

0

0

0

Proceeds from disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

47

0

0

0

-

-

-

-

25

55

45

26

14

0

0

0

-

-

-

-

-

-

-

-

78

0

0

0

Acquisition of Sterilator, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

95,261

0

0

0

-

-

-

-

Acquisitions, net of cash acquired

702,947

682,576

40,644

43,537

47,248

44,143

87,488

84,641

75,983

72,621

70,044

69,902

71,772

72,486

94,528

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

1,550

2,070

2,067

2,067

22,150

0

0

0

Restricted cash for IMS Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net asset value adjustment for PuriCore Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

-

-

-

-

-

-

-

-

-

-

-

-772

-188

-606

-339

184

293

-285

-241

-482

-707

118

358

631

487

488

262

-107

36

-27

-44

285

148

269

314

0

0

0

Net cash used in investing activities

-755,185

-746,517

-133,029

-129,797

-130,479

-114,183

-125,186

-115,053

-102,148

-98,264

-97,062

-96,442

-97,167

-95,628

-112,982

-111,577

-102,935

-108,267

-52,294

-78,522

-72,443

-71,973

-47,432

-19,381

-25,477

-53,281

-52,046

-50,599

-43,667

-6,595

-103,115

-103,438

-110,040

-111,620

-35,721

0

0

0

Borrowings of long-term debt

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49,647

0

0

0

-

-

-

-

Repayments of long-term debt

14,957

15,082

15,207

12,707

5,000

2,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings under revolving credit facility

322,900

341,400

50,000

50,000

66,000

21,000

82,300

82,300

74,300

74,300

74,000

74,000

74,500

74,500

96,500

96,500

93,000

105,000

47,000

0

0

0

-

-

-

-

-

-

-

-

46,941

46,941

54,441

54,446

28,000

0

0

0

Repayments under term loan facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

7,500

10,000

10,000

10,000

10,000

10,000

10,000

10,000

10,000

10,000

10,000

10,000

0

0

0

Repayments under revolving credit facility

27,900

17,900

7,000

176,000

181,000

189,000

208,300

58,300

63,300

67,300

64,000

61,000

59,000

61,000

59,000

56,000

55,000

51,000

49,000

48,000

44,000

39,000

37,500

33,000

30,500

33,000

30,000

30,500

28,000

26,500

22,000

17,500

15,000

12,000

15,000

0

0

0

Proceeds from exercises of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

608

617

750

843

634

654

615

1,758

1,817

1,994

2,605

2,155

2,372

2,507

2,387

2,864

2,555

0

0

0

Debt issuance costs

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Finance lease liabilities

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefits from stock-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,179

2,092

2,246

2,184

3,168

3,238

3,557

4,268

4,391

4,704

4,304

4,558

2,875

2,641

3,176

2,665

1,970

1,600

1,206

974

776

0

0

0

Purchases of treasury stock

4,086

4,066

4,741

5,486

5,477

5,540

7,074

6,739

6,598

6,516

6,910

6,568

6,564

6,810

3,732

3,742

3,735

3,591

3,727

3,781

3,806

4,094

4,439

4,547

4,437

4,293

2,252

2,301

3,053

3,189

1,904

1,886

1,532

1,516

1,290

0

0

0

Net cash provided by financing activities

657,866

686,641

14,702

45,391

64,106

14,171

57,137

10,795

-2,063

-5,357

-2,751

601

3,150

1,375

29,942

34,485

32,216

48,724

-6,105

23,135

16,248

7,482

-18,949

-44,383

-35,398

1,007

4,424

4,075

-1,031

-37,399

64,503

69,016

78,856

82,353

2,977

0

0

0

Effect of exchange rate changes on cash and cash equivalents

3,748

1,538

1,834

-557

-3,008

-1,287

-350

489

1,974

1,349

-163

-633

-234

-804

-581

-274

-272

-522

-732

-641

-980

-472

-186

-161

-236

-14

18

-52

41

-40

-192

-113

136

285

344

0

0

0

Increase (decrease) in cash and cash equivalents

-12,301

-14,745

-49,562

-568

31,054

26,810

57,513

21,043

15,626

11,085

8,217

5,375

2,747

-4,996

-3,353

133

-2,488

1,417

-61

891

4,386

1,261

-2,295

-6,195

-7,119

587

3,890

5,642

5,136

8,220

11,776

8,988

5,614

3,692

-4,202

0

0

0